Status | Study |
Withdrawn |
Study Name: A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia Condition: Chronic Myeloid Leukemia, Blast Crisis Acute Myeloid Leukemia Date: 2008-01-03 Interventions: Drug: Imatinib Mesylate Imatin |
Completed |
Study Name: An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condition: Leukemia, Myeloid, Chronic Date: 2007-10-01 Interventions: Drug: Glivec®/Gleevec® Chemotherapy |
Completed |
Study Name: Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis) Condition: Leukemia, Myeloid, Chronic Date: 2007-03-20 Interventions: Drug: panobinostat LBH589 |
No longer available |
Study Name: Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant Condition: Chronic Myelogenous Leukemia Date: 2006-12-18 Interventions: Drug: nilotinib |
Completed |
Study Name: 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia Condition: Accelerated Phase Chronic Myelogenous Leukemia Atypical Chronic Myeloid Leukemia, BCR-ABL1 N Date: 2006-09-26 Interventions: Drug: fludarabine phosphate Gi |
Completed |
Study Name: An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis Condition: Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis Date: 2005-09-12 Interventions: Drug: imatinib mesylate Other Name: Gleevec/Glivec |
Terminated |
Study Name: Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) Condition: Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic, Accelerated-Phase Date: 2005-06-20 Interventions: Drug: Homoharringtonine |
Completed |
Study Name: BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia Condition: Leukemia, Myeloid, Chronic-phase Leukemia, Lymphoblastic, Acute, Philadelphia-positive Date: 2005-02-14 Interventions: Drug: Dasatinib Tablets, Oral, 15- 240 mg, Once or twice daily, 0-3 years depending on response. |
Completed |
Study Name: Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate Condition: Chronic Myeloid Leukemia Blast Crisis Date: 2005-01-13 Interventions: Drug: Dasatinib Tablets, Oral, 70 mg, twice daily, Until disease progression or intolerable toxicity, sw |
Completed |
Study Name: Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Condition: Chronic Myeloid Leukemia Leukemia, Lymphoblastic, Acute, Philadelphia-positive Date: 2005-01-12 Interventions: Drug: Dasatinib Tablets, Oral, 70 mg, twice daily, Until disease progression or untolerable toxicity, sw |